Zhijian Qian Ph.D. is a tenured full Professor in the Department of Medicine, at the University of Florida. Before that, he had been serving as a tenured Associate Professor of medicine at the University of Illinois at Chicago for several years.
Dr. Qian received his Ph.D. degree from Shanghai Institute of Cell Biology, Chinese Academy of Science, China, and then conducted postdoc training at the University of Illinois at Chicago and the University of Chicago. He established his independent research laboratory in 2010 in the department of Medicine at University of Illinois at Chicago.
Dr. Qian is a scholar of The Leukemia & Lymphoma Society (2018) and Research of the year. His research has been supported by multiple RO1 grants from NIH and other private foundations.
Dr. Fang Yu received his Ph.D. degree at the Institute of biomedical sciences, East China Normal University. He mainly focused on the epigenetic studies and protein post-translational modifications (PTMs), particularly protein SUMOylation and its role in transcriptional regulation during his Ph.D. stage. After that, he joined Dr. Qian’s lab as a postdoc in 2018. Since then he shifted his research directions to work on deciphering the basic mechanisms for RNA m6A methylation and its role in tumorigenesis and leukemogenesis.
Dr. Chunjie Yu joined the Qian Laboratory in September 2015. She obtained her Ph.D. in Biochemistry and Molecular biology from Wuhan University in China. Her graduate research focused on the effects of Chinese medicine, Bacalein treatment, on AMKL (Acute Megakaryoblastic Leukemia) and the investigation of how MPL mutations influence the development of Myeloproliferative Neoplasms. Her current research is focused on hematopoietic malignancy, megakaryocyte development, and combinational therapeutic strategies.
Dr. Yafang Li got her Ph.D. degree from the Institute of Hematology, Peking Union Medical College in China. She mainly focused on small molecular compounds targeting leukemia stem cells and the Hippo signaling pathway in hematopoiesis and leukemogenesis. She joined Dr. Qian’s lab in 2021 to continue studying the mechanisms and targeted therapy of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS).
Dr. Sanhui Gao gained her Ph.D degree at the Institute of Zoology, Chinese Academy of Sciences. She joint Dr. Qian’s lab in 2022. Her current research is focus on deciphering the function and mechanism of RNA modifier in leukemia and hematopoiesis
Dr. Xiulin Jiang received his Ph.D. degree at the Kunming Institute of Zoology, Chinese Academy of Sciences. He mainly focused on the function and mechanism of long non-coding RNA in cancer stem cell self-renewal and drug resistance during his Ph.D. stage. After that, he joined Dr. Qian’s lab as a postdoc in 2023. Since then he shifted his research directions to work on deciphering the function and mechanisms of RNA-binding protein in tumorigenesis and leukemogenesis.
Dr. Dantong Shang got her Ph.D. degree in cell biology at Wuhan University in China. She mainly focused on the molecular mechanisms of specification of human PGCs (primordial germ cell) by using a 3-D organoids induced by iPSCs (induced pluripotent stem cells) during her Ph.D. stage. After graduation, she joined Dr. Sheng’s lab in the second xiangya hospital of central south university as a postdoc in 2023, and then she worked in Dr. Qian’s lab as a visiting scholar. Since then, her research is focused on the mechanisms and targeted therapy of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS).
Yixiao Yuan is a Ph.D student from the Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. She mainly focused on the function and mechanism of DNA methylation in breast cancer drug resistance during his Ph.D. stage . She joined Dr. Qian’s lab in 2023 to continue studying the function and mechanisms of m6A-binding protein in the maintenance of tumorigenesis of HNSCC.
Zhexin Liu joined the University of Florida in 2019. Majored in pre-professional biology for 4 years, he graduate with a B.S. degree in 2023 Spring. During his undergradute research, he focused on the genetics of the C. Elegants stress responses and then the genetics of AML .